| Product Name | MF | CAS | Details |
|---|
| Prasugrel hydrochloride impurity | Details |
| Cinacalcet HCl impurity | Details |
| Temozolomide | C6H6N6O2 | 85622-93-1 | Details |
| Vortioxetine (Lu AA21004) HBr | C18H23BrN2S | 960203-27-4 | Details |
| (R)-2-benzyl-4-(tert-butoxy)-4-oxobutanoic acid | C15H20O4 | 122225-33-6 | Details |
| (S)-4-benzyl-3-(3-phenylpropanoyl)oxazolidin-2-one | C19H19NO3 | 96930-27-7 | Details |
| (S)-tert-butyl (3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)carbamate | C16H28N2O3 | 1404457-07-3 | Details |
| 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole | C12H15N3O5S2 | 1280210-80-1 | Details |
| 2,2'-bis(bromomethyl)-1,1'-binaphthalene | C22H16Br2 | 86631-56-3 | Details |
| 2,2'-bis(chloromethyl)-1,1'-binaphthalene | C22H16Cl2 | Details |
| 2-chloro-6-morpholino-4H-pyran-4-one | C9H10ClNO3 | Details |
| 5-chloro-2-methylpyridin-3-amine | C6H7ClN2 | 89639-36-1 | Details |
| 7-Deaza-2'-C-ethynyladenosine | C13H14N4O4 | 1044589-82-3 | Details |
| 8-aminonaphthalene-1,3,6-trisulfonic acid | C10H10NNaO9S3 | 5398-34-5 | Details |
| benzyl 2,3-dihydroxypropanoate | C10H12O4 | 73573-57-6 | Details |
| BIBW2992 Afatinib | C24H25ClFN5O3 | 439081-18-2 | Details |
| Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
| Cabazitaxel | C45H57NO14 | 183133-96-2 | Details |
| Colistin sulfate | 2(C52H98N16O13).5(H2SO4) | 1264-72-8 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| Docetaxel | C43H53NO14 | 114977-28-5 | Details |
| Doripenem hydrate | C15H26N4O7S2 | 364622-82-2 | Details |
| Dronedarone | C31H44N2O5S | 141626-36-0 | Details |
| Fosaprepitant | C23H22F7N4O6P | 172673-20-0 | Details |
| Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
| Ledipasvir (acetone) | C52H60F2N8O7 | 1441674-54-9 | Details |
| methyl 5-(bromomethyl)thiophene-2-carboxylate | C7H7BrO2S | Details |
| Mitiglinide IMpurity | Details |
| Omarigliptin (MK-3102) | C17H20F2N4O3S | 1226781-44-7 | Details |
| MK-3102 interMediate | C16H19F2NO4 | 951127-25-6 | Details |
| N-Octyl-D-Gluconamide | C14H29NO6 | 18375-61-6 | Details |
| Raltitrexed | C21H22N4O6S | 112887-68-0 | Details |
| SYR-472;Trelagliptin (succinate) | C22H26FN5O6 | 1029877-94-8 | Details |
| TAK-438 | C21H20FN3O6S | 1260141-27-2 | Details |
| TEDIZOLID PHOSPHATE | C17H16FN6O6P | 856867-55-5 | Details |
| tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]carbaMate | C16H19F2NO3 | 1172623-98-1 | Details |
| 4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate) | C15H24ClN3O8S2 | 1276666-12-6 | Details |
| 2-BROMO-5-NITROANISOLE | C7H6BrNO3 | 77337-82-7 | Details |
| 4-BROMO-3-METHOXYANILINE | C7H8BrNO | 19056-40-7 | Details |
| 6-broMo-4-chloro-7-Methoxy-quinoline | C10H7BrClNO | 476660-71-6 | Details |
| Iloperidone | C24H27FN2O4 | 133454-47-4 | Details |
| Apixaban | C25H25N5O4 | 503612-47-3 | Details |
| Ezetimibe Impurity | C24H23F2NO2 | 1510820-22-0 | Details |
| Palboceb Impurities | Details |
| -5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole hydrochloride | C13H17Cl2N3O | 1266664-66-7 | Details |
| Eluxadoline | C32H35N5O5 | 864821-90-9 | Details |
| (E)-5-(benzo[d]thiazol-2-yl)-3-ethyl-2-(2-(methyl(phenyl)amino)vinyl)-1-phenyl-1H-benzo[d]imidazol-3-ium iodide | C31H27N4S.I | 681281-88-9 | Details |
| Biapenem | C15H18N4O4S | 120410-24-4 | Details |
| GTS-21 | C19H22Cl2N2O2 | 156223-05-1 | Details |
| methyl 4-chloro-7-methoxyquinoline-6-carboxylate | C12H10ClNO3 | 205448-66-4 | Details |
| SODIUM FERRIC GLUCONATE | C24H44FeNaO28 | 34089-81-1 | Details |
| MK-3102 | C23H23ClN6O2 | 1030377-33-3 | Details |
| Entecavir | C12H15N5O3 | 142217-69-4 | Details |
| 6-bromo-4-chloro-3-nitroquinoline | C9H4BrClN2O2 | 723281-72-9 | Details |
| 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid | C10H9N3O2 | 956317-36-5 | Details |
| (R)-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole | C13H16ClN3O | 1266975-27-2 | Details |
| Fosaprepitant dimeglumine | C30H39F7N5O11P | 265121-04-8 | Details |
| TUBERCIDIN | C11H14N4O4 | 69-33-0 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||